First Trimester Screening in Canada
First trimester screening is offered early in pregnancy to estimate the chance that a baby has certain chromosome conditions.
It is not a diagnosis. It does not tell you with certainty that the baby has or does not have a condition. It gives a risk estimate, and that result helps decide whether more testing, counselling, or follow-up is recommended.
In Canada, first trimester screening usually happens between 10 and 13 weeks of pregnancy, depending on the type of screening used and the province or territory where you receive care. Some screening options include an ultrasound. Some include blood work. Some include both. Non-invasive prenatal testing, also called NIPT or cell-free DNA screening, is another blood test option that is available from around 9 or 10 weeks of pregnancy, depending on the lab and local program.
The most important thing for parents to understand is this: screening is a choice. Your provider should explain what is available, what each test looks for, what the result means, what the test cannot tell you, and what happens next if the result comes back higher risk.
What First Trimester Screening Means
First trimester screening checks the chance of certain chromosome conditions in pregnancy.
The most commonly discussed conditions are:
Trisomy 21, also called Down syndrome.
Trisomy 18, also called Edwards syndrome.
Trisomy 13, also called Patau syndrome.
Some screening options also give information about sex chromosome differences, depending on the test used. Not every screening test looks for the same conditions. This is why your provider needs to explain exactly which screening option is being offered in your province or territory.
A screening test does not confirm a chromosome condition. It places the pregnancy into a lower-risk or higher-risk category. A lower-risk result is reassuring, but it is not a guarantee. A higher-risk result does not mean the baby definitely has the condition. It means more information is recommended.
Reasons Screening Is Offered
Screening is offered so parents can receive early information about the pregnancy.
Some parents want as much information as possible. Some want time to prepare. Some want to know whether additional testing is recommended. Some prefer not to screen because the information would not change their decisions. All of these positions deserve respectful counselling.
The role of the provider is not to pressure you. The role of the provider is to explain:
What the screening checks for.
When the screening must be done.
How accurate it is.
What the possible results mean.
What follow-up is offered after a higher-risk result.
Whether the screening is publicly funded or private-pay.
What your choices are if you decline.
Screening belongs to informed decision-making. It should not feel like something that just happens automatically without explanation.
First Trimester Screening Happens
Timing matters.
Most first trimester screening options happen during a narrow window. If the window is missed, the same test cannot always be done later.
In many Canadian programs, the nuchal translucency ultrasound is done between 11 and just under 14 weeks of pregnancy. Some first trimester blood screening windows are also tied to this stage. NIPT is available earlier than many ultrasound-based screening pathways, commonly from around 9 or 10 weeks depending on the lab.
The exact dates depend on the screening program.
A parent-friendly timeline looks like this:
Around 9 to 10 weeks: NIPT becomes available through some labs and programs.
Around 10 to 13 weeks: First trimester blood screening can be offered depending on the program.
Around 11 to just under 14 weeks: The nuchal translucency ultrasound window is used in many Canadian screening pathways.
Around 10 to 13 weeks: First trimester screening discussions should already be happening so you do not miss the correct timing.
If you are already 10 weeks pregnant and no one has discussed screening with you, ask now. Do not wait until the next routine appointment if that appointment is weeks away.
Screening Options in Canada
Screening options differ across Canada.
The names and availability change by province, territory, clinic, lab access, funding rules, and pregnancy risk factors. Your provider should tell you what is available where you live.
Common screening options include:
First trimester combined screening.
Enhanced first trimester screening.
Integrated prenatal screening.
Serum integrated prenatal screening.
Quad screening in the second trimester when first trimester screening is missed or not available.
Non-invasive prenatal testing, also called NIPT or cell-free DNA screening.
The exact combination depends on your local program. Some parents are offered an NT ultrasound plus blood work. Some are offered blood work without NT depending on location and eligibility. Some are offered NIPT because of age, screening result, twin pregnancy, previous history, ultrasound finding, or another qualifying factor. Some choose private-pay NIPT.
This is why a Canada-wide article must be careful. There is no single test that every Canadian parent receives in exactly the same way.
What the NT Scan Is
The NT scan is a nuchal translucency ultrasound.
It measures the fluid-filled space at the back of the baby’s neck in early pregnancy. All babies have some fluid in this area. A thicker measurement increases the chance of certain chromosome conditions and some structural concerns, especially heart-related concerns.
The NT scan is done in a specific time window because the measurement is only useful during that stage of pregnancy. The baby also needs to be in a suitable position, and the scan needs to be done by a trained ultrasound professional.
The NT scan can be part of a first trimester screening calculation. In some places, it is also arranged on its own to gather early information about baby’s growth and development.
An increased NT is not a diagnosis. It is a finding that needs follow-up.
What Happens During the NT Ultrasound
During the NT ultrasound, the sonographer measures the baby and checks whether the pregnancy is at the correct gestational age for the screening window.
The scan usually checks:
Gestational age.
Baby’s size.
Whether there is one baby or more than one.
Basic early development visible at this stage.
The nuchal translucency measurement.
The ultrasound is not the same as the detailed anatomy scan later in pregnancy. It does not check every organ in detail. It gives early information, and the NT measurement is used as part of screening or risk assessment.
If the baby is not in a good position, the sonographer can need more time. Sometimes the parent is asked to move, walk, empty the bladder, or wait briefly so the baby changes position.
What the Blood Tests Check
First trimester blood screening looks at pregnancy-related substances in the pregnant person’s blood.
The exact markers depend on the screening program. Common markers include pregnancy-associated plasma protein A, called PAPP-A, and free beta-hCG. These markers are interpreted together with factors such as gestational age, age of the pregnant person, and sometimes the NT measurement.
The blood test does not look directly at the baby’s chromosomes. It measures patterns in the blood that are associated with a higher or lower chance of certain chromosome conditions.
This is why blood screening is a risk estimate, not a diagnosis.
What NIPT Is
NIPT stands for non-invasive prenatal testing.
It is a blood test from the pregnant person. It analyzes small fragments of placental DNA circulating in the blood. Because the placenta usually shares the baby’s genetic makeup, NIPT gives a more accurate screening result for common chromosome conditions than traditional serum screening.
NIPT commonly screens for trisomy 21, trisomy 18, and trisomy 13. Some versions also screen for sex chromosome differences and other chromosome changes, depending on the lab and test menu.
NIPT is still a screening test. It is more accurate than many traditional screening options, but it is not diagnostic. A high-risk NIPT result needs confirmatory diagnostic testing before anyone treats it as a confirmed diagnosis.
NIPT is not always publicly funded. Public funding depends on province, territory, age, pregnancy history, ultrasound findings, previous screening results, twin pregnancy status, and other criteria. Private-pay NIPT is also available in many areas.
What Conditions Screening Looks For
First trimester screening most often focuses on chromosome conditions.
The main ones are:
Trisomy 21: Down syndrome.
Trisomy 18: Edwards syndrome.
Trisomy 13: Patau syndrome.
These conditions happen when there is an extra copy of a chromosome. Screening estimates the chance that the pregnancy is affected.
Some screening tests also give information about sex chromosome differences. Some expanded NIPT panels screen for more conditions, but broader screening does not always mean better screening. Expanded panels can create more uncertain findings, more false positives, and more complicated counselling.
A good provider should explain exactly what your chosen screening test includes.
What Screening Does Not Check For
First trimester screening does not check for everything.
It does not rule out all genetic conditions.
It does not rule out all birth differences.
It does not replace the anatomy ultrasound later in pregnancy.
It does not diagnose autism, cerebral palsy, developmental delay, or every inherited condition.
It does not guarantee a healthy baby.
It does not replace routine prenatal care.
This matters because many parents hear “low risk” and think it means everything has been checked. That is not accurate. A low-risk screening result is reassuring for the specific conditions screened, but it is not a full-body guarantee.
Screening answers a narrow question. Prenatal care continues to answer other questions as pregnancy progresses.
How Results Are Reported
Screening results are usually reported as low risk or screen negative, or as increased risk or screen positive.
Some results are given as a ratio, such as 1 in 10,000 or 1 in 100. The wording depends on the province, lab, and test.
A low-risk result means the chance of the screened condition is lower than the program’s cut-off. It does not mean zero risk.
A screen-positive result means the chance is higher than the program’s cut-off. It does not mean the baby definitely has the condition.
NIPT results are often reported as low risk or high risk for specific conditions. Sometimes the result is “no result” or “failed” because there was not enough fetal fraction, the sample could not be interpreted, or another technical issue occurred. A no-result NIPT needs follow-up with the provider. It should not be ignored.
What a Low-Risk Result Means
A low-risk result is reassuring.
It means the screening did not show a higher chance for the condition or conditions included in that test. Most parents with low-risk results continue routine prenatal care.
But low risk does not mean no risk. No screening test catches every affected pregnancy. No screening test checks for every possible condition.
If the ultrasound later shows a concern, or if there is a strong family history, your provider can still recommend additional assessment even after a low-risk screening result.
The correct interpretation is this:
Low risk means reassuring for the screened conditions.
It does not mean the pregnancy has been fully cleared of every medical concern.
What a Higher-Risk Result Means
A higher-risk result is not a diagnosis.
It means the screening result crossed the cut-off where more information is recommended.
This is the part parents need to hear clearly: a screen-positive result means “more assessment is needed,” not “your baby definitely has this condition.”
The next step depends on the type of screening, gestational age, ultrasound findings, personal values, and local referral pathway.
Your provider can recommend:
Genetic counselling.
Review of dating and ultrasound findings.
NIPT if it has not already been done.
A detailed ultrasound at the appropriate time.
Referral to maternal-fetal medicine or genetics.
Diagnostic testing discussion.
The exact path depends on the result and where you live.
What Happens After an Increased NT Measurement
An increased NT measurement needs follow-up.
A thicker NT can be associated with chromosome conditions, heart differences, genetic syndromes, or structural differences. It can also occur in pregnancies where later testing is reassuring.
The follow-up plan depends on the measurement, gestational age, other ultrasound findings, and screening results.
Your provider can recommend:
Genetic counselling.
NIPT or diagnostic testing discussion.
Follow-up ultrasound.
Detailed anatomy assessment later.
Fetal heart assessment when indicated.
Referral to maternal-fetal medicine.
The key point is direct: an increased NT is not something to ignore, and it is not a diagnosis on its own. It is a marker that needs proper assessment.
Limitations of First Trimester Screening
First trimester screening has limits.
Traditional serum screening can miss some affected pregnancies.
Traditional serum screening can also produce false positives.
NIPT has very high accuracy for common trisomies, especially trisomy 21, but it is still a screening test.
NIPT can have false positives.
NIPT can have false negatives.
NIPT can return no result.
NIPT reflects placental DNA, which usually matches the baby, but not always.
Screening performance differs by condition. A test that is very strong for trisomy 21 is not automatically equally strong for every chromosome condition or every expanded panel item.
This is why diagnostic testing exists. Diagnostic testing is the pathway used when a parent needs a confirmed answer rather than a risk estimate.
Screening vs. Diagnostic Testing
Screening estimates chance.
Diagnostic testing confirms or rules out specific chromosome conditions with much greater certainty.
First trimester screening, serum screening, NT ultrasound, and NIPT are screening tools. They do not diagnose.
Diagnostic testing includes procedures that collect pregnancy-related cells for chromosome analysis. Your provider or genetics team explains these options if they are recommended. This article does not need to explain the procedures in detail because that belongs in a separate diagnostic testing guide.
For this topic, the core message is enough:
Screening tells you whether risk is low or higher.
Diagnostic testing gives a confirmed result for the condition being tested.
A higher-risk screen leads to a conversation, not an automatic diagnosis.
What If Screening Is Missed?
If the first trimester screening window is missed, you still have options.
Second trimester screening can be available depending on the province or territory. NIPT can often be done later in pregnancy as well, depending on timing, funding, and clinical situation.
Do not assume you have no choices because you missed one window. Call your provider and ask what screening options remain available.
The right question is:
“What screening can still be done at my current gestational age?”
That gives your provider a practical starting point.
What If You Are Having Twins?
Screening in twin pregnancy is more complex.
Some screening tests perform differently with twins. NIPT can be available for twins, but the test menu, accuracy, funding, and interpretation depend on the lab and pregnancy details.
NT ultrasound can still provide useful information in twin pregnancy, but results need careful interpretation.
If you are carrying twins, ask your provider whether your screening pathway is different and whether referral to a specialist or genetics counsellor is recommended.
What If You Used IVF?
IVF pregnancies still need screening discussions.
Preimplantation genetic testing, when used, does not replace all prenatal screening. It lowers certain risks depending on what was tested, but it does not check everything and does not remove the need for routine pregnancy care.
Dating is usually more exact after IVF because embryo transfer dates are known. That helps with timing screening windows.
If this is an IVF pregnancy, bring your fertility clinic records to the first prenatal care provider. Your provider uses that information to date the pregnancy accurately and plan screening.
Should Everyone Have Screening?
Screening should be offered and explained. It should not be forced.
Some parents choose screening because they want early information. Some choose it because they would consider diagnostic testing if the result is higher risk. Some choose it because they want time to prepare medically, emotionally, and practically. Some decline because the information would not change their decisions or because they do not want the stress of risk estimates.
The provider’s job is to support informed choice.
Good counselling includes:
What the test checks.
What it misses.
What a positive result means.
What a negative result means.
What follow-up is available.
What happens if you decline.
Whether there is a cost.
You should not be made to feel irresponsible for choosing screening or declining screening.
Questions to Ask Before Screening
Before saying yes to a screening test, ask clear questions.
What screening options are available in my province or territory?
Which conditions does this test screen for?
Does this test include an NT ultrasound?
When exactly does the test need to be done?
Is the test publicly funded for me?
If it is private-pay, what is the cost?
How accurate is this test for trisomy 21?
How accurate is it for trisomy 18 and trisomy 13?
Can this test give a false positive?
Can this test give a false negative?
What happens if the result is higher risk?
What happens if the result is low risk?
What happens if the result comes back as no result?
Will I be referred to genetics or maternal-fetal medicine if needed?
How long do results take?
Who will call me with the result?
These questions help you make a decision based on facts, not fear.
Questions to Ask After a Higher-Risk Result
If you receive a higher-risk result, pause before assuming the worst.
Ask:
Which condition is the result higher risk for?
What is the actual risk number?
Is this a screening result or a diagnostic result?
What is the chance this is a false positive?
What follow-up do you recommend?
Should I speak with a genetics counsellor?
Is NIPT an option now?
Is diagnostic testing recommended?
How soon do I need to decide?
What ultrasound follow-up is needed?
Who will coordinate the next appointment?
This is the moment where vague reassurance is not enough. You need clear next steps.
How to Handle the Waiting Period
Waiting for screening results can feel heavy.
Parents often check their phones constantly, replay the ultrasound, and read too much online. That reaction is understandable, but it does not make the waiting easier.
The practical approach is to ask before leaving the appointment:
When will results come back?
Who will call me?
Will I be called for both normal and abnormal results?
Can I view results online?
What number should I call if I do not hear back?
This gives you structure. Waiting without a plan creates more anxiety.
A Clinician’s Plain-Language Summary
First trimester screening is useful because it gives early risk information about certain chromosome conditions.
The NT scan measures fluid at the back of baby’s neck during a narrow early window.
Blood screening measures pregnancy-related markers and calculates risk.
NIPT analyzes placental DNA fragments in the pregnant person’s blood and is more accurate for common trisomies than traditional serum screening.
None of these are diagnostic.
A low-risk result is reassuring.
A higher-risk result means more assessment is recommended.
An increased NT needs proper follow-up.
Your province or territory determines which options are publicly funded and how referrals work.
Key Takeaway
First trimester screening in Canada is a set of optional screening choices offered early in pregnancy, usually between 10 and 13 weeks depending on the test.
The main screening options include NT ultrasound with blood work, integrated or serum screening pathways, and NIPT. These tests most often screen for trisomy 21, trisomy 18, and trisomy 13. Some tests screen for additional chromosome differences.
Screening is not diagnosis. It estimates chance.
Low-risk results are reassuring but not a guarantee.
Higher-risk results do not confirm a condition. They mean more counselling, testing, or follow-up is recommended.
Ask your provider early, because screening windows are time-sensitive. The right screening choice is the one you understand, consent to, and can interpret clearly with your care team.
